Epithelial-trophoblast interactions in human embryo implantation: role for interleukin 11 and leukemia inhibitory factor
人胚胎植入中上皮-滋养层相互作用:白细胞介素 11 和白血病抑制因子的作用
基本信息
- 批准号:nhmrc : 388916
- 负责人:
- 金额:$ 33.05万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Project Grants
- 财政年份:2006
- 资助国家:澳大利亚
- 起止时间:2006-01-01 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Infertility, spontaneous abortion and pre-eclampsia are major clinical problems. Female infertility is frequently due to implantation failure and many IVF embryos fail to implant. Appropriate development of the placenta is critical to the outcome of pregnancy and inadequate placentation can result in spontaneous abortion. However, if the pregnancy continues with a poorly developed placenta, the mother is likely to develop pre-eclampsia with subsequent major adverse outcomes for both mother and baby. Pre-clampsia is the most common cause of low birth weight infants and also of maternal death. Low birth weight, which is commonly an outcome of a pregnancy with pre-eclampsia, correlates with disorders later in life (including hypertension, diabetes, coronary heart disease and obesity). Interleukin (IL)-11 and leukemia inhibitory factor (LIF) are among very few molecules known to be critical for embryo implantation in the mouse. Their roles in human infertility are not well understood, although there is evidence that decreased LIF is associated with implantation failure in women. The distribution of these molecules within the uterus and placenta in primates suggests they have important roles in preparing the uterine lining for implantation and for development of a placenta in women. This project will examine how IL-11 and LIF that are locally produced at implantation sites affect the human uterus and the formation of the placenta. There is still no means of readily diagnosing endometrial infertility in women or of establishing whether the placenta is developing adequately. These studies will provide new critical information regarding the roles of these two molecules and their potential usefulness as targets for much- needed diagnostic and therapeutic tools for infertility and major diseases associated with pregnancy. Application of such new tests will produce lifelong benefits to the health of both the mother and child.
不孕症、自然流产和先兆子痫是主要的临床问题。女性不孕症通常是由于植入失败,许多体外受精胚胎未能植入。胎盘的适当发育对妊娠结局至关重要,胎盘发育不充分可导致自然流产。然而,如果胎盘发育不良继续妊娠,母亲可能会发展为先兆子痫,随后对母亲和婴儿都有重大不良后果。钳前症是低出生体重婴儿和产妇死亡的最常见原因。低出生体重通常是子痫前期妊娠的结果,与以后的生活失调(包括高血压、糖尿病、冠心病和肥胖)有关。白细胞介素(IL)-11和白血病抑制因子(LIF)是已知对小鼠胚胎植入至关重要的极少数分子。它们在人类不孕症中的作用尚不清楚,尽管有证据表明LIF降低与女性着床失败有关。这些分子在灵长类动物子宫和胎盘中的分布表明,它们在准备子宫内膜着床和女性胎盘发育中起着重要作用。该项目将研究在植入部位局部产生的IL-11和LIF如何影响人类子宫和胎盘的形成。目前仍没有办法轻易地诊断女性子宫内膜不孕症或确定胎盘是否发育充分。这些研究将为这两个分子的作用提供新的关键信息,以及它们作为不孕不育和妊娠相关主要疾病急需的诊断和治疗工具的潜在用途。这种新检测的应用将对母亲和孩子的健康产生终生的益处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prof Evdokia Dimitriadis其他文献
Prof Evdokia Dimitriadis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prof Evdokia Dimitriadis', 18)}}的其他基金
Mechanistic and translational studies in female reproductive health
女性生殖健康的机制和转化研究
- 批准号:
nhmrc : GNT1117033 - 财政年份:2017
- 资助金额:
$ 33.05万 - 项目类别:
Research Fellowships
Facilitating endometrial receptivity to improve pregnancy outcomes
促进子宫内膜容受性,改善妊娠结局
- 批准号:
nhmrc : 1120689 - 财政年份:2017
- 资助金额:
$ 33.05万 - 项目类别:
Project Grants
Mechanistic and translational studies in female reproductive health
女性生殖健康的机制和转化研究
- 批准号:
nhmrc : 1117033 - 财政年份:2017
- 资助金额:
$ 33.05万 - 项目类别:
Research Fellowships
Facilitating endometrial receptivity to improve pregnancy outcomes
促进子宫内膜容受性,改善妊娠结局
- 批准号:
nhmrc : GNT1120689 - 财政年份:2017
- 资助金额:
$ 33.05万 - 项目类别:
Project Grants
Critical Regulators of Embryo Implantation
胚胎植入的关键调节因子
- 批准号:
nhmrc : 1019826 - 财政年份:2012
- 资助金额:
$ 33.05万 - 项目类别:
Research Fellowships
Interleukin 11 and leukaemia inhibitory factor: important regulators of embryo implantation and placentation
白细胞介素11和白血病抑制因子:胚胎着床和胎盘的重要调节因子
- 批准号:
nhmrc : 550905 - 财政年份:2009
- 资助金额:
$ 33.05万 - 项目类别:
Career Development Fellowships
相似海外基金
Mechanisms Underlying Preeclampsia: Cellular Interactions at the Fetal-Maternal Interface
先兆子痫的潜在机制:胎儿-母体界面的细胞相互作用
- 批准号:
489404 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别:
Operating Grants
POPI: Placenta, Opioids and Perinatal Implications
POPI:胎盘、阿片类药物和围产期影响
- 批准号:
10748428 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别:
Developmental Programming of the Liver and Kidney in Fetal Growth with or without Gene Therapy
有或没有基因治疗的胎儿生长中肝脏和肾脏的发育规划
- 批准号:
10663585 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别:
Lymphocyte function in inflammatory disorders of human endometrium and decidua
淋巴细胞在人子宫内膜和蜕膜炎症性疾病中的功能
- 批准号:
10673395 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别:
Modeling human trophoblast-NK cell interactions in term and preterm birth
足月和早产时人类滋养层 - NK 细胞相互作用的建模
- 批准号:
10770207 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别:
Multimodal Analysis of Gestational Health and Placental Injury in Opioid-Affected Pregnancies
阿片类药物影响妊娠的妊娠健康和胎盘损伤的多模态分析
- 批准号:
10750475 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别:
Next-Generation Engineered NK Cell Immunotherapy for Ovarian Cancer
下一代卵巢癌工程 NK 细胞免疫疗法
- 批准号:
10709230 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别:
Identifying placental injury pathways in women of African ancestry with severe preeclampsia
确定患有严重先兆子痫的非洲血统女性的胎盘损伤途径
- 批准号:
10742342 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别:
Investigating the molecular mechanism of P-gp/NHERF-1 network at feto maternal interface and role of paracrine signaling of EVs containing drug transporter proteins
研究胎儿母体界面P-gp/NHERF-1网络的分子机制以及含有药物转运蛋白的EV的旁分泌信号传导的作用
- 批准号:
10748250 - 财政年份:2023
- 资助金额:
$ 33.05万 - 项目类别: